title: [Low-grade cutaneous B-cell lymphoma: Failure of intralesional rituximab (Mabthera)].
authors.forename: C
authors.initials: C
authors.lastname: Abasq
authors.forename: A-B
authors.initials: AB
authors.lastname: Duval-Modeste
authors.forename: P
authors.initials: P
authors.lastname: Courville
authors.forename: P
authors.initials: P
authors.lastname: Joly
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D007275:Injections, Intravenous; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D012074:Remission Induction; D000069283:Rituximab; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab